Literature DB >> 26399285

HIV-TB co-infection in children: associated factors and access to HIV services in Lagos, Nigeria.

O J Daniel1, O A Adejumo2, M Gidado3, H A Abdur-Razzaq4, E O Jaiyesimi5.   

Abstract

BACKGROUND: Human immunodeficiency virus (HIV) and tuberculosis (TB) are the leading causes of death from infectious disease worldwide. The World Health Organization estimates that the prevalence of HIV among children with TB in moderate to high prevalence countries ranges between 10% and 60%. This study aimed to determine the access to HIV services of HIV-TB co-infected children.
METHODS: A retrospective review of data of children diagnosed with TB in Lagos State, Nigeria from 1 January 2012 to 31 December 2013.
RESULTS: A total of 1199 children aged between 0 and 14 years were diagnosed with TB. Of 1095 (91.3%) who underwent testing for HIV, 320 (29.2%) were HIV seropositive. The male-to-female ratio of HIV-TB positive outcomes was 1:0.9. Of the 320 HIV-TB co-infected children, 57 (17.8%) were aged <1 year, 86 (26.9%) 1-4 years and 186 (58.1%) 5-14 years; 186/320 (58.1%) began cotrimoxazole preventive therapy (CPT), and 151 (47.2%) were put on antiretroviral treatment (ART). ART uptake was not significantly higher in facilities where HIV-TB services were co-located (P > 0.05).
CONCLUSION: The uptake of CPT and ART was low. There is a need to intensify efforts to improve access to HIV services in Lagos State, Nigeria.

Entities:  

Keywords:  HIV services; HIV-TB; Nigeria; access; childhood TB; tuberculosis

Year:  2015        PMID: 26399285      PMCID: PMC4576771          DOI: 10.5588/pha.15.0027

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  26 in total

Review 1.  Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.

Authors:  K Grimwade; G H Swingler
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  TB/HIV integration at primary care level: A quantitative assessment at 3 clinics in Johannesburg, South Africa.

Authors:  L Page-Shipp; Y Voss De Lima; K Clouse; J de Vos; L Evarts; J Bassett; I Sanne; A Van Rie
Journal:  South Afr J HIV Med       Date:  2012-09       Impact factor: 2.744

3.  Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa.

Authors:  H J Zar; D Hanslo; E Tannenbaum; M Klein; A Argent; B Eley; J Burgess; K Magnus; E D Bateman; G Hussey
Journal:  Acta Paediatr       Date:  2001-02       Impact factor: 2.299

4.  The burden of childhood tuberculosis and the accuracy of community-based surveillance data.

Authors:  B J Marais; A C Hesseling; R P Gie; H S Schaaf; N Beyers
Journal:  Int J Tuberc Lung Dis       Date:  2006-03       Impact factor: 2.373

5.  Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa.

Authors:  Kate Grimwade; A Willem Sturm; Andrew J Nunn; Daniel Mbatha; Dawn Zungu; Charles F Gilks
Journal:  AIDS       Date:  2005-01-28       Impact factor: 4.177

6.  Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment.

Authors:  Marcel Yotebieng; Annelies Van Rie; Harry Moultrie; Stephen R Cole; Adaora Adimora; Frieda Behets; Tammy Meyers
Journal:  AIDS       Date:  2010-06-01       Impact factor: 4.177

7.  Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa.

Authors:  P M Jeena; P Pillay; T Pillay; H M Coovadia
Journal:  Int J Tuberc Lung Dis       Date:  2002-08       Impact factor: 2.373

Review 8.  Tuberculosis and HIV co-infection in children.

Authors:  Elisabetta Venturini; Anna Turkova; Elena Chiappini; Luisa Galli; Maurizio de Martino; Claire Thorne
Journal:  BMC Infect Dis       Date:  2014-01-08       Impact factor: 3.090

9.  Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial.

Authors:  Andrew J Nunn; Peter Mwaba; Chifumbe Chintu; Alwyn Mwinga; Janet H Darbyshire; Alimuddin Zumla
Journal:  BMJ       Date:  2008-07-10

Review 10.  HIV and tuberculosis in India.

Authors:  Soumya Swaminathan; G Nagendran
Journal:  J Biosci       Date:  2008-11       Impact factor: 2.795

View more
  6 in total

1.  BCG Vaccination and Mother-to-Infant Transmission of HIV.

Authors:  Sindhuja Murali Kilapandal Venkatraman; Ranjit Sivanandham; Ivona Pandrea; Cristian Apetrei
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

2.  Deaths during tuberculosis treatment among paediatric patients in a large tertiary hospital in Nigeria.

Authors:  Aishatu L Adamu; Muktar H Aliyu; Najiba Aliyu Galadanci; Baba Maiyaki Musa; Muktar A Gadanya; Auwalu U Gajida; Taiwo G Amole; Imam W Bello; Safiya Gambo; Ibrahim Abubakar
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

Review 3.  Prevalence of extrapulmonary tuberculosis among people living with HIV/AIDS in sub-Saharan Africa: a systemic review and meta-analysis.

Authors:  Hussen Mohammed; Nega Assefa; Bezatu Mengistie
Journal:  HIV AIDS (Auckl)       Date:  2018-11-05

4.  Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study.

Authors:  Ermias Sisay Chanie; Getnet Asmare Gelaye; Tesfaye Yimer Tadesse; Dejen Getaneh Feleke; Wubet Taklual Admas; Eshetie Molla Alemu; Melkalem Mamoye Azanaw; Sofonyas Abebaw Tiruneh; Alemayehu Digssie Gebremariam; Binyam Minuye Birhane; Wubet Alebachew Bayih; Getachew Aragie
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

5.  Incidence of tuberculosis in children on antiretroviral therapy: a retrospective cohort study.

Authors:  Aklilu Endalamaw; Eshetu Hailesilassie Engeda; Nega Tezera
Journal:  BMC Res Notes       Date:  2018-10-20

Review 6.  Tuberculosis and HIV-An Update on the "Cursed Duet" in Children.

Authors:  Samantha H-L Fry; Shaun L Barnabas; Mark F Cotton
Journal:  Front Pediatr       Date:  2019-04-25       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.